Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Other financing activities (2020 - 2025)

GoHealth's Other financing activities history spans 5 years, with the latest figure at $8.0 million for Q3 2025.

  • For Q3 2025, Other financing activities rose 76.17% year-over-year to $8.0 million; the TTM value through Sep 2025 reached -$1.1 million, down 123.83%, while the annual FY2022 figure was $1.6 million, 60.05% down from the prior year.
  • Other financing activities for Q3 2025 was $8.0 million at GoHealth, up from -$13.6 million in the prior quarter.
  • Across five years, Other financing activities topped out at $8.0 million in Q3 2025 and bottomed at -$13.6 million in Q4 2024.
  • The 4-year median for Other financing activities is $1.7 million (2022), against an average of $667142.9.
  • The largest YoY upside for Other financing activities was 131.3% in 2021 against a maximum downside of 60.27% in 2021.
  • A 4-year view of Other financing activities shows it stood at $2.5 million in 2021, then tumbled by 103.36% to -$84000.0 in 2022, then tumbled by 16071.43% to -$13.6 million in 2024, then soared by 158.72% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Other financing activities are $8.0 million (Q3 2025), -$13.6 million (Q4 2024), and $4.5 million (Q3 2024).